BTIG analyst David Larsen maintained a Buy rating on DocGo (DCGO – Research Report) on January 5 and set a price target of $13.00. The company’s shares closed last Friday at $4.93.
According to TipRanks, Larsen is an analyst with an average return of -9.6% and a 31.01% success rate. Larsen covers the Healthcare sector, focusing on stocks such as Apollo Medical Holdings, Health Catalyst, and LifeMD.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for DocGo with a $11.60 average price target, representing a 135.29% upside. In a report released on January 2, Northland Securities also maintained a Buy rating on the stock with a $12.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Based on DocGo’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $186.55 million and a net profit of $4.76 million. In comparison, last year the company earned a revenue of $104.32 million and had a net profit of $3.15 million
Based on the recent corporate insider activity of 43 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DCGO in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
DocGo (DCGO) Company Description:
Motion Acquisition Corp is a blank check company.
Read More on DCGO:
- TipRanks ‘Perfect 10’ List: These 2 Top-Scoring Stocks Are Flirting With a Bottom
- 3 Best Stocks to Buy Now, 12/29/2023, According to Top Analysts
- 3 Best Stocks to Buy Now, 12/19/2023, According to Top Analysts
- 3 Best Stocks to Buy Now, 12/7/2023, According to Top Analysts
- 3 Best Stocks to Buy Now, 6/12/2023, According to Top Analysts
